Publications To Date


    Filter Publications

    PAGE 2 OF 65 | DISPLAYING 16 - 30 OF 973 RESULTS

    Woo YM et al., Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation, , PLoS One, Jun 25, 2019

    Wu F et al., Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer, , Int. J. Mol. Sci., Jun 24, 2019

    Shi L. et. al., A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma , , Mod Pathol., Jun 23, 2019

    Harnan S et al., Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis., , Health Technol Assess., Jun 23, 2019

    Lu C et al., Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes., , J Immunother Cancer., Jun 22, 2019

    Gong Y et al., Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade, , Mol Cancer Res., Jun 20, 2019

    Nowakowski GS et al., Variable global distribution of cell-of-origin from the ROBUST phase 3 study in diffuse large B-cell lymphoma., , Haematologica., Jun 20, 2019

    Cao L et al., Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma., , Cancer Lett, Jun 20, 2019

    Beck TN et al., Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer., , BMC Cancer, Jun 19, 2019

    Sceneay J et al., Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer., , Cancer Discov., Jun 19, 2019

    Zhu GQ et al., Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients., , J Transl Med., Jun 18, 2019

    Jaeger AM et al., Rebalancing protein homeostasis enhances tumor antigen presentation., , Clin Cancer Res, Jun 18, 2019

    Keane C et al., The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma., , Eur J Haematol., Jun 18, 2019

    Pileri SA et al., Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment, , Oncotarget, Jun 18, 2019

    Kacherovsky N et al., Traceless aptamer-mediated isolation of CD8+ T cells for chimeric antigen receptor T-cell therapy, , Nat Biomed Eng., Jun 17, 2019